Financial Analysis

COMMITMENTS AND CONTINGENCIES Guarantees and Letters of Credit The Company has various bank guarantees, letters of credit and surety bonds which are used to support its ongoing business operations, satisfy governmental requirements associated with pending litigation in various jurisdictions and the payment of customs duties. As of December 31, 2025, the Company had a total capacity of approximately $209 million of bank guarantees, commercial guarantees, standby letters of credit and surety bonds with various financial institutions. Included in the above aggregate amount was a total of approximately $11 million for other assessments in Brazil for various income tax and indirect tax disputes related to fiscal years 1998-2011. There was a total of approximately $50 million outstanding under the bank guarantees, standby letters of credit and commercial guarantees as of December 31, 2025. In order to challenge the assessments in these cases in Brazil, the Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in the amount of approximately $7 million as of December 31, 2025. Litigation The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss if reasonably estimable. A loss contingency is accrued in the Companys Consolidated Financial Statements if it is probable that a liability has been incurred and the amount of the loss …

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

DEBT Debt consisted of the following at December 31: (DOLLARS IN MILLIONS) Effective Interest Rate 2025 2024 2025 Notes (1)(2) 1.22 % 1,000 2026 Euro Notes (1) 1.93 % 940 827 2027 Notes (1)(2) 1.56 % 804 1,209 2028 Notes (1) 4.57 % 399 398 2030 Notes (1)(2) 2.21 % 1,238 1,507 2040 Notes (1)(2) 3.04 % 341 771 2047 Notes (1)(2) 4.44 % 392 495 2048 Notes (1)(2) 5.12 % 674 787 2050 Notes (1)(2) 3.21 % 888 1,568 2026 Term Loan Facility (1) 4.88 % 413 Revolving Credit Facility (3) Commercial Paper (4) 314 Bank overdrafts and other 4 2 Total debt $ 5,994 $ 8,977 Less: Short term borrowings (1,254) (1,413) Total Long-term debt $ 4,740 $ 7,564 _______________________ (1) Amount is net of unamortized discount and debt issuance costs. (2) Included in the tender offers described below. (3) Borrowings under the Revolving Credit Facility are subject to interest at varying spreads above quoted market rates and a commitment fee is paid on the total unused borrowings. (4) The effective interest rate of commercial paper issuances fluctuates as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Refer to Commercial Paper below. Tender Offers On May 20, 2025, the Company completed tender offers to purchase for cash certain of its outstanding series of Senior Notes for an aggregate purchase price, excluding accrued and unpaid interest, of $2.0 billion. The carrying value of this series of Senior Notes purchased as a result of these tender offers was $2 …

DebtDisclosureTextBlock · excerpt; the full note is in the filing

STOCK COMPENSATION PLANS The Company has various equity plans under which its officers, senior management, other key employees and Board of Directors may be granted options to purchase IFF common stock or other forms of stock-based awards. The cost of all employee stock-based awards is principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures. Total stock-based compensation expense included in the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) was as follows: December 31, (DOLLARS IN MILLIONS) 2025 2024 2023 Equity-based awards $ 88 $ 77 $ 65 Liability-based awards 1 2 2 Total stock-based compensation 89 79 67 Less: Tax benefit (18) (15) (11) Total stock-based compensation, net of tax $ 71 $ 64 $ 56 The shareholders of the Company approved the Companys Amended and Restated 2021 Stock Award and Incentive Plan on May 1, 2024 (the 2021 A&R SAIP). The shareholders of the Company approved the Companys 2021 Stock Award and Incentive Plan (the 2021 Plan) on May 5, 2021. The 2021 Plan replaced the Companys 2015 Stock Award and Incentive Plan (the 2015 Plan) and the Companys 2010 Stock Award and Incentive Plan (the 2010 Plan), and provides the source for future deferrals of cash into deferred stock under the Companys Deferred Compensation Plan (with the Deferred Compensation Plan being deemed a subplan under the 2010 Plan for the sole purpose of funding deferrals under the IFF Share Fun …

DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing

GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill Movements in goodwill attributable to each reportable segment during the years ended December 31, 2024 and 2025 were as follows: (DOLLARS IN MILLIONS) Nourish Taste Food Ingredients Scent Health & Biosciences Pharma Solutions Total Balance at December 31, 2023 $ 3,489 $ $ $ 1,490 $ 4,391 $ 1,265 $ 10,635 Transferred to assets held for sale (1) (55) (1,248) (1,303) Reduction from business divestitures (2) (10) (10) Foreign Exchange (104) (25) (96) (17) (242) Other (5) (5) Balance at December 31, 2024 3,315 1,465 4,295 9,075 Reallocation of goodwill in segment reorganization (3,315) 2,176 1,153 (14) Transferred to assets held for sale (1) (6) (6) Reduction from business divestitures (2) (8) (8) Impairment (1,153) (1,153) Foreign exchange 134 43 184 361 Balance at December 31, 2025 $ $ 2,296 $ $ 1,508 $ 4,465 $ $ 8,269 _______________________ (1) For 2025, related to the Tobacco Flavoring business. For 2024, related to the Pharma Solutions disposal group and the Nitrocellulose business. The Company recognized $64 million of impairment related to the Pharma Solutions disposal group classified as held for sale as of December 31, 2024. See Note 3 for additional information. (2) For 2025, relates to the divestiture of the Rene Laurent business. For 2024, relates to the divestiture of the Flavors & Essences UK business. See Note 3 for additional information. The goodwill balance at December 31, 2025 was net of accumulated goo …

GoodwillAndIntangibleAssetsDisclosureTextBlock · excerpt; the full note is in the filing

INCOME TAXES Earnings before income taxes consisted of the following: December 31, (DOLLARS IN MILLIONS) 2025 2024 2023 U.S. income (loss) before taxes $ (1,421) $ (810) $ (1,777) Foreign income (loss) before taxes 1,009 1,118 (741) Total income (loss) before taxes $ (412) $ 308 $ (2,518) The income tax provision consisted of the following: December 31, (DOLLARS IN MILLIONS) 2025 2024 2023 Current tax provision Federal $ (178) $ (44) $ 47 State and local 4 9 Foreign 391 399 393 Total current tax provision 217 364 440 Deferred tax provision Federal (144) (203) (161) State and local (16) (28) 32 Foreign (110) (92) (242) Total deferred tax benefit (270) (323) (371) Total (benefit) provision for income taxes $ (53) $ 41 $ 69 Effective Tax Rate Reconciliation As further described in Note 1, Summary of Significant Accounting Policies, the Company has adopted the guidance in ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, or ASU 2023-09. The following table is a reconciliation of the U.S. federal statutory tax rate of 21% to the Companys effective tax rate for the year ended December 31, 2025 in accordance with the guidance in ASU 2023-09: Year Ended December 31, 2025 Total % Earnings from continuing operations, before income tax expense $ (412) U.S. Federal Statutory Tax Rate (87) 21.1 % United States State and Local Income Taxes (a) (13) 3.2 % Federal Effect of Cross-Border Tax Laws Global intangible low taxed income 36 (8.7) % Other (3) 0.7 % …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

LEASES The Company has leases for corporate offices, manufacturing facilities, research and development facilities and certain transportation and office equipment, the majority of which are operating leases. The Companys leases have remaining lease terms of up to 50 years, some of which include options to extend the leases for up to 15 years. The components of lease expense were as follows: December 31, (DOLLARS IN MILLIONS) 2025 2024 2023 Operating leases Operating lease cost $ 123 $ 126 $ 137 Variable lease cost 68 58 56 Total operating lease cost $ 191 $ 184 $ 193 Finance leases Finance lease cost $ 14 $ 12 $ 10 Supplemental cash flow information related to leases was as follows: December 31, (DOLLARS IN MILLIONS) 2025 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows for operating leases $ 131 $ 122 $ 122 Operating cash flows for finance leases 2 1 1 Financing cash flows for finance leases 12 10 8 Right-of-use assets obtained in exchange for lease obligations Operating leases 77 69 49 Finance leases 20 16 22 Supplemental balance sheet information related to leases was as follows: December 31, (DOLLARS IN MILLIONS) 2025 2024 Operating Leases Operating lease right-of-use assets $ 579 $ 589 Current operating lease obligations (2) 92 82 Operating lease liabilities 533 550 Total operating lease liabilities $ 625 $ 632 Finance Leases Finance lease right-of-use assets (1) $ 32 $ 27 Current finance lease obligations (2) 12 10 Fi …

LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing

Recent Accounting Pronouncements In December 2025, the FASB issued ASU 2025-12 Codification Improvements to address suggestions received from stakeholders on the Accounting Standards Codification and to make other incremental improvements to U.S. GAAP. The update represents changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. The amendments make the Codification easier to understand and apply. The guidance is effective for fiscal years beginning after December 15, 2026, including interim periods within those fiscal years. The Company is currently evaluating the impact of this guidance on our Consolidated Financial Statements and related disclosures. In December 2025, the FASB issued ASU 2025-11 to amend the guidance in Interim Reporting (Topic 270). The update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The guidance is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years. The Company does not expect any significant impact on its financial condition or results of operations upon adoption. In December 2025, the F …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

EMPLOYEE BENEFITS The Company has pension and/or other retirement benefit plans covering approximately 20% of active employees. In 2007, the Company amended its U.S. qualified and non-qualified pension plans under which accrual of future benefits was suspended for all participants that did not meet the rule of 70 (age plus years of service equal to at least 70 as of December 31, 2007). Pension benefits are generally based on years of service and compensation during the final years of employment. Plan assets consist primarily of equity securities and corporate and government fixed income securities. Substantially all pension benefit costs are funded as accrued; such funding is limited, where applicable, to amounts deductible for income tax purposes. Certain other retirement benefits are provided by general corporate assets. The Company sponsors a qualified defined contribution plan covering substantially all U.S. employees. Under this plan, effective January 1, 2023, the Company matches 100% of the first 6% of participants contributions. In addition to pension benefits, certain health care and life insurance benefits are provided to qualifying U.S. employees upon retirement from IFF. Such coverage is provided through insurance plans with premiums based on benefits paid. The Company does not generally provide health care or life insurance coverage for retired employees of foreign subsidiaries; such benefits are provided in most foreign countries by government-sponsored plans, a …

PensionAndOtherPostretirementBenefitsDisclosureTextBlock · excerpt; the full note is in the filing

RESTRUCTURING AND OTHER CHARGES Restructuring and other charges primarily consist of separation costs for employees including severance, outplacement and other employee benefit costs (Severance), charges related to the write-down of fixed assets of plants to be closed (Fixed asset write-down) and all other related restructuring (Other) costs. All restructuring and other charges are separately stated on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss). N&B Merger Restructuring Liability During 2024, the Company incurred approximately $2 million of charges related to a lease impairment and no charges related to severance. During 2023, the Company incurred approximately $2 million of lease termination costs and lease impairment charges. From the inception of the program in 2021 to its completion, there were a total of 215 headcount reductions and the Company expensed a total of $49 million, of which $35 million related to severance and $14 million related to lease termination, lease impairment, and other costs. As of December 31, 2024, the program was completed. 2023 Restructuring Program In December 2022, the Company announced a restructuring program mainly related to headcount reduction to improve its organizational and operating structure, drive efficiencies and achieve cost savings. From the inception of the restructuring program, there were a total of 670 actual headcount reductions. During 2024 and 2023, the Company incurred approximately $4 …

RestructuringAndRelatedActivitiesDisclosureTextBlock · excerpt; the full note is in the filing

SEGMENT INFORMATION Effective January 1, 2025, the Company implemented a reorganization of its internal structure, which impacted the way the CODM, the Chief Executive Officer, allocates resources and assesses financial performance. As a result, the Company updated its reportable segments beginning with the first quarter of 2025. Specifically, the former Nourish segment has been separated into two new reportable segments: Taste and Food Ingredients. The Taste segment (formerly the Flavors business within Nourish) includes flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment (formerly the Ingredients business within Nourish) includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as soy and pea protein solutions, emulsifiers, and sweeteners. In addition, immaterial business transfers occurred between Food Ingredients and Pharma Solutions, and between Health & Biosciences and Taste. Accordingly, the Companys reportable segments as of January 1, 2025 are: Taste, Food Ingredients, Health & Biosciences, Scent, and Pharma Solutions. The Company also adjusted its corporate cost allocations to align with the new organizational structure and updated operating model, consistent with how management assesses performance effective January 1, 2025. Segment information for the year ended December 31, 2024 and 2023 has been recast to refl …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

SHAREHOLDERS EQUITY Dividends Cash dividends declared per share were $1.60, $1.60 and $3.24 for the years ended December 31, 2025, 2024 and 2023, respectively. The Consolidated Balance Sheets reflect $102 million of dividends payable at December 31, 2025. This amount relates to a cash dividend of $0.40 per share declared in December 2025 and paid in January 2026. Dividends declared, but not paid as of December 31, 2024 and December 31, 2023 were $102 million ($0.40 per share) and $207 million ($0.81 per share), respectively. Share Repurchase Program On August 5, 2025, the Company announced that its Board of Directors has authorized a new share repurchase program with a total value of $500 million. The program began on October 1, 2025 and does not have a specified term or termination date. Under the program, the Company is authorized to repurchase shares of common stock in privately negotiated transactions, and/or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act, and in block trades, or a combination of the foregoing. The Board will review the share repurchase program periodically and may authorize adjustment of its term and size. The Company plans to fund repurchases from available cash and cash provided by operating activities. During 2025, the Company repurchased approximatel y 584,000 shares of common stock at a cost of approximately $38 million. …

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

COMMITMENTS AND CONTINGENCIES Guarantees and Letters of Credit The Company has various bank guarantees, letters of credit and surety bonds which are used to support its ongoing business operations, satisfy governmental requirements associated with pending litigation in various jurisdictions and the payment of customs duties. As of September 30, 2025, the Company had a total of approximately $211 million of available bank guarantees, commercial guarantees, standby letters of credit and surety bonds with various financial institutions. There was a total of approximately $51 million outstanding under the bank guarantees, standby letters of credit and commercial guarantees as of September 30, 2025. The Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in Brazil for various income tax and indirect tax disputes related to fiscal years 1998-2011 in the amount of approximately $7 million as of September 30, 2025. Litigation The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss if reasonably estimable. A loss contingency is accrued in the Companys Consolidated Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly sensitive a …

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

DEBT Debt consisted of the following: (DOLLARS IN MILLIONS) Effective Interest Rate September 30, 2025 December 31, 2024 2025 Notes (1)(2) 1.22 % $ $ 1,000 2026 Euro Notes (1) 1.93 % 938 827 2027 Notes (1)(2) 1.56 % 805 1,209 2028 Notes (1) 4.57 % 399 398 2030 Notes (1)(2) 2.21 % 1,239 1,507 2040 Notes (1)(2) 3.04 % 342 771 2047 Notes (1)(2) 4.44 % 392 495 2048 Notes (1)(2) 5.12 % 674 787 2050 Notes (1)(2) 3.21 % 888 1,568 2026 Term Loan Facility (1) 4.88 % 413 Revolving Credit Facility (3) Commercial paper (4) 370 Bank overdrafts and other 2 2 Total debt 6,049 8,977 Less: Short-term borrowings (1,308) (1,413) Total Long-term debt $ 4,741 $ 7,564 _______________________ (1) Amount is net of unamortized discount and debt issuance costs. (2) Included in the tender offers described below. (3) Borrowings under the Revolving Credit Facility are subject to interest at varying spreads above quoted market rates and a commitment fee is paid on the total unused borrowings. (4) The effective interest rate of commercial paper issuances fluctuates as short-term interest rates and demand fluctuate, and deferred debt issuance costs are immaterial. Refer to Commercial Paper below. Repayments of Debt 2025 Notes On September 30, 2025, the Company made a $500 million debt repayment related to the 2025 Notes, which was primarily funded from commercial paper issuances. Tender Offers On May 20, 2025, the Company completed tender offers to purchase for cash certain of its outstanding series of Seni …

DebtDisclosureTextBlock · excerpt; the full note is in the filing

STOCK COMPENSATION PLANS The Company has various plans under which its officers, senior management, other key employees and directors may be granted equity-based awards. Equity awards outstanding under the plans include PRSUs, restricted stock units (RSUs), stock-settled appreciation rights (SSARs) and Long-Term Incentive Plan awards. Liability-based awards outstanding under the plans are cash-settled RSUs. Stock-based compensation expense and related tax benefits were as follows: Three Months Ended September 30, Nine Months Ended September 30, (DOLLARS IN MILLIONS) 2025 2024 2025 2024 Equity-based awards $ 21 $ 16 $ 72 $ 59 Liability-based awards 1 1 3 Total stock-based compensation expense 21 17 73 62 Less: Tax benefit (4) (3) (14) (12) Total stock-based compensation expense, after tax $ 17 $ 14 $ 59 $ 50 As of September 30, 2025, there was approximately $86 million o f total unrecognized compensation cost related to non-vested awards granted under the equity incentive plans. …

DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing

GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill Movements in goodwill attributable to each reportable segment for the nine months ended September 30, 2025 were as follows: (DOLLARS IN MILLIONS) Nourish Taste Food Ingredients Scent Health & Biosciences Pharma Solutions Total Balance at January 1, 2025 $ 3,315 $ $ $ 1,465 $ 4,295 $ $ 9,075 Reallocation of goodwill in segment reorganization (3,315) 2,176 1,153 (14) Transferred to assets held for sale (6) (6) Impairment (1,153) (1,153) Foreign exchange 125 44 179 348 Balance at September 30, 2025 $ $ 2,295 $ $ 1,509 $ 4,460 $ $ 8,264 Goodwill Impairment Test Effective January 1, 2025, the Company reorganized its Nourish segment into two new reportable segments: Taste and Food Ingredients, to align with changes in the Companys internal management reporting structure. As a result of this change, goodwill previously allocated to the Nourish reporting unit was reallocated between the new Taste and Food Ingredients reporting units. In accordance with ASC 350, the Company performed a quantitative goodwill impairment test on the former Nourish reporting unit immediately prior to the change, and separately tested goodwill for the new Taste and Food Ingredients reporting units following the reorganization. Based on the results of the impairment testing, the Company determined that the carrying amount of the Food Ingredients reporting unit exceeded its estimated fair value, and accordingly recognized a goodwill impairment charge of …

GoodwillAndIntangibleAssetsDisclosureTextBlock · excerpt; the full note is in the filing

INCOME TAXES The effective tax rate for the three months ended September 30, 2025 was 26.8%, which was primarily due to the mix of pre-tax income and losses in different jurisdictions. The effective tax rate for the nine months ended September 30, 2025 was 10.1%, which was primarily driven by the tax benefit resulting from the entity realignment project, offset in part by the impact of business divestitures, a goodwill impairment charge that is mostly non-taxable and changes in the mix of earnings post-divestitures. During the nine months ended September 30, 2025, a one-time tax benefit of $361 million was achieved as part of the realignment project which is partially offset by the execution costs to implement. On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) was enacted in the U.S. The OBBBA permanently extends key provisions of the Tax Cuts and Jobs Act of 2017, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense deduction. Further, the OBBBA makes significant changes to the U.S. international tax framework, most notably the Global Intangible Low-Taxed Income (GILTI) regime. The legislation has multiple effective dates, with certain provisions effective in 2025 and others effective in 2026. ASC 740, Income Taxes, requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. Based on the Companys assessment, the OBBBA is expected to h …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

LEASES The Company has leases for corporate offices, manufacturing facilities, research and development facilities and certain transportation and office equipment. The Companys leases have remaining lease terms of up to 50 years, some of which include options to extend the leases for up to 15 years. The components of lease expense were as follows: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended (DOLLARS IN MILLIONS) September 30, 2025 September 30, 2024 September 30, 2025 September 30, 2024 Operating leases Operating lease cost $ 32 $ 31 $ 90 $ 95 Variable lease cost 11 14 43 42 Total operating lease cost $ 43 $ 45 $ 133 $ 137 Finance leases Finance lease cost $ 4 $ 3 $ 10 $ 9 Supplemental cash flow information related to leases was as follows: Nine Months Ended Nine Months Ended (DOLLARS IN MILLIONS) September 30, 2025 September 30, 2024 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows for operating leases $ 99 $ 90 Operating cash flows for finance leases 1 1 Financing cash flows for finance leases 9 7 Right-of-use assets obtained in exchange for lease obligations Operating leases 84 44 Finance leases 14 12 Operating lease right-of-use assets are presented in Operating lease right-of-use assets and finance lease right-of-use assets are presented in Other assets on the Consolidated Balance Sheets. Operating lease liabilities are presented in Operating lease liabilities and finance lease liabilities are prese …

LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing

Recent Accounting Pronouncements In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal use Software (Subtopic 350-40): Targeted improvements to the Accounting for Internal-use Software. The ASU was issued to modernize the accounting for internal-use software by eliminating the accounting consideration of software project development stages and clarifying the threshold applied to begin capitalizing costs. This guidance is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with early adoption permitted. Public business entities are permitted to adopt the ASU prospectively or retrospectively. The Company is currently evaluating the impact of this guidance on our Consolidated Financial Statements and related disclosures. In July 2025, the FASB issued ASU 2025-05, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient to measure credit losses on accounts receivable and contract assets. This guidance is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company will adopt the ASU prospectively and is currently evaluating the impact of this guidance on our Consolidated Financial Statements and related disclosures. In November 2024, the FASB issued ASU 2024-03, Income …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

EMPLOYEE BENEFITS The Companys defined benefit plan expenses included the following components: (DOLLARS IN MILLIONS) U.S. Plans (1) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Interest cost on projected benefit obligation (3) $ 1 $ 6 $ 2 $ 17 Expected return on plan assets (3) (6) (18) Net amortization and deferrals (3) (1) 1 3 Net periodic benefit (income) cost $ $ 1 $ 2 $ 2 (DOLLARS IN MILLIONS) Non-U.S. Plans Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Service cost for benefits earned (2) $ 6 $ 6 $ 16 $ 18 Interest cost on projected benefit obligation (3) 8 9 26 27 Expected return on plan assets (3) (12) (13) (35) (38) Net amortization and deferrals (3) 2 2 5 Net periodic benefit (income) cost $ 2 $ 4 $ 9 $ 12 _______________________ (1) The International Flavors & Fragrances Inc. Pension Plan (the Plan) was formally terminated on April 1, 2024, and settlements of the terminated Plan occurred during November 2024. The Company continues to administer several smaller non-qualified U.S. pension plans. (2) Included as a component of Operating profit (loss). (3) Included as a component of Other expense, net. The Company expects to contribute a total of $5 million to its U.S. pension plans and a total of $22 million to its non-U.S. pension plans during 2025. During the nine months ended September 30, 2025, $3 million of contributions were made with respect to the Companys non-qualified U.S. pe …

PensionAndOtherPostretirementBenefitsDisclosureTextBlock · excerpt; the full note is in the filing

RESTRUCTURING AND OTHER CHARGES Restructuring and other charges primarily consist of separation costs for employees including severance, outplacement and other employee benefit costs (Severance), charges related to the write-down of fixed assets of plants to be closed (Fixed asset write-down) and all other related restructuring (Other) costs. All restructuring and other charges are separately stated on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss). IFF Productivity Program Beginning in 2024, the Company began undertaking a productivity enhancement program aimed at improving productivity and optimizing its organizational footprint to align with business needs. This program will involve a series of actions, including ceasing operations in select manufacturing plants, consolidating leased and owned real estate space, and reducing employee headcount. The Company aims to substantially complete this productivity program by December 31, 2026. The estimated total cost of the program initiatives ranges from $100 million to $120 million. The anticipated cash charges include employee-related costs such as severance, contract terminations, and dismantling costs. Additionally, non-cash charges related to assets, such as fixed asset write downs, are expected. For the three and nine months ended September 30, 2025, the Company incurred approximately $16 million and $54 million, respectively, in severance costs in connection with the IFF Productivity Program. A …

RestructuringAndRelatedActivitiesDisclosureTextBlock · excerpt; the full note is in the filing

SEGMENT INFORMATION Effective January 1, 2025, the Company implemented a reorganization of its internal structure, which impacted the way the CODM, the Chief Executive Officer, allocates resources and assesses financial performance. As a result, the Company updated its reportable segments beginning with the first quarter of 2025. Specifically, the former Nourish segment has been separated into two new reportable segments: Taste and Food Ingredients. The Taste segment (formerly the Flavors business within Nourish) includes flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment (formerly the Ingredients business within Nourish) includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as soy and pea protein solutions, emulsifiers, and sweeteners. In addition, immaterial business transfers occurred between Food Ingredients and Pharma Solutions, and between Health & Biosciences and Taste. Accordingly, the Companys reportable segments as of January 1, 2025 are: Taste, Food Ingredients, Health & Biosciences, Scent, and Pharma Solutions. The Company also adjusted its corporate cost allocations to align with the new organizational structure and updated operating model, consistent with how management assesses performance effective January 1, 2025. Segment information for the three months and nine months ended September 30, 2024 has bee …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing